Last updated 2026-07-26
- Raised $5M Series A, Oct 2023
- Raised $1.6M Seed round led by Boston Scientific, Aug 2023
- Raised $800k grant, Apr 2021
Total raised
$7.4M
Last: Undisclosed Round 2023-11
Stage
Series A
Founded
2020
Headcount
7
HQ
Or Yehuda, Israel
Sector
Health Tech & Life Sciences
About
VeinWay is an Israeli medical device startup developing Traversa, the first dedicated sharp venous recanalization device for chronically occluded veins. The company's mission is to improve access to healthcare for patients suffering from chronic venous disease by providing interventional radiologists with tools to open, treat, and effectively heal patients with chronic venous occlusions. VeinWay was established under the umbrella of MEDX Xelerator, a medical device incubator.
Funding history · 4 rounds · $7.4M total
2023-10
A Round
$5.0M
2023-08
Seed
$1.6M
★ Boston Scientific★ Consensus Business Group (CBG)
2021-04
Grant
$800K
2020-11
Grant
$35K
Headcount over time
From 2 (2021-09) to 4 (2025-12) · +2 (+100%) · 14 points · source: Finder history + radar grounding
Q&A
- What is VeinWay's primary focus?
- VeinWay is an Israeli medical device startup developing Traversa, a dedicated sharp venous recanalization device for chronically occluded veins, aiming to improve access to healthcare for patients with chronic venous disease.
- When was VeinWay founded and under what umbrella?
- VeinWay was founded in 2020 under the umbrella of MEDX Xelerator, a medical device incubator.
- Which investors participated in VeinWay's Seed round?
- In March 2023, VeinWay raised a Seed round with participation from MEDX Xelerator and MassChallenge.
- What is the current employee count for VeinWay?
- VeinWay currently has 7 employees, falling within the 1-10 employee bucket.
- What is the name of VeinWay's core product?
- VeinWay's core product is called Traversa, which is designed as the first dedicated sharp venous recanalization device for chronically occluded veins.
- What is VeinWay's current funding stage?
- VeinWay is currently in the Series A funding stage.
- Who are the co-founders of VeinWay?
- The co-founders of VeinWay are Jordan Pollack, who serves as CEO, and Ben Friesem, who serves as CTO.
Team · 2
Jordan Pollack
Founder · CEO & Co-Founder
Ben Friesem
Founder · CTO & Co-Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
medical-devicescardiologyvasculartreatmentsmedical-technologiescardiovascular
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | veinway.com |
|---|---|
| linkedin.com/company/72137520 | |
| YouTube | youtube.com/@VeinWayTraversa |
Identifiers & details
| Legal name | VeinWay Ltd. |
|---|---|
| Founded | 2020 |
| Employees (exact) | 7 |
Radar intelligence
Patents
| EPO | 1 |
|---|
Web history (Wayback)
| Domain | veinway.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516276490 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2020-11-05 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 1 — annual_report (1) |
| Registered address | שרון אריאל 8 אור יהודה |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-07 | דו~ח שנתי |